Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

13 projects found matching your search criteria :

  1. Dual-acting 5-HT6/5-HT7 receptor antagonists: exploring beneficial effects for the treatment of neurodegenerative disord...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Michał Kamiński

    Uniwersytet Jagielloński

  2. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

  3. (Micro)RNA and informatics approaches for diagnosis, prognosis and treatment of Alzheimer's disease and Dementia

    Call: JPND Call 2023 , Panel: NZ3

    Principal investigator: dr hab. Agnieszka Fiszer

    Instytut Chemii Bioorganicznej PAN

  4. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Emilia Aleksandra Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

  5. Crystallographic analysis of RNA-ligand complexes. Towards rational design oflead compounds for development of therapies...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Ludmiła Kiliszek

    Instytut Chemii Bioorganicznej PAN

  6. Psychedelics as Therapeutic Candidates in Neurodegenerative Disorders Treatment– a Study in Spinocerebellar Ataxia Type ...

    Call: SONATINA 5 , Panel: NZ4

    Principal investigator: dr Urszula Joanna Kozłowska

    Instytut Chemii Bioorganicznej PAN

  7. Physical exercise as a natural mechanism inducing neuroregeneration. Search for the new protein markers and therapeutic ...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Zofia Kuter-Nowak

    Instytut Farmakologii PAN

  8. Oligomer-Focused Screening and Individualized Therapeutics to target Neurodegenerative Disorders

    Call: JPND2019 , Panel: NZ1

    Principal investigator: dr Piotr Hańczyc

    Uniwersytet Warszawski, Wydział Fizyki

  9. Impact of early-life stress on maturation, permeability of blood brain-barrier and neuroinflammatory processes activatio...

    Call: PRELUDIUM 12 , Panel: NZ4

    Principal investigator: Anna Katarzyna Solarz

    Instytut Farmakologii PAN

  10. Nanomolecular antioxidants: biological basis of targeted therapy of neurodegenerative diseases.

    Call: SONATA BIS 6 , Panel: NZ7

    Principal investigator: dr hab. Izabela Anna Sadowska-Bartosz

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

  11. Search for the functionally selective 5-HT1A receptor agonists as new pharmacological tools in the development of treatm...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  12. An effect of lipid metabolism changes on the function of skeletal and heart muscles and neurodegeneration process in mou...

    Call: PRELUDIUM 9 , Panel: NZ4

    Principal investigator: Marta Urszula Tomczyk

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  13. The influence of dimethyl fumarate on the spatial memory, neurogenesis, neurodegeneration and cerebral imflammation in t...

    Call: SONATA 5 , Panel: NZ4

    Principal investigator: dr Irena Maria Majkutewicz

    Uniwersytet Gdański, Wydział Biologii